Your session is about to expire
← Back to Search
Other
Melatonin Use in the Intensive Care Elderly Population (MICE Trial)
Phase 4
Waitlist Available
Research Sponsored by MICE Trial Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Non-ventilated Patients over the age of 65
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Pivotal Trial
All Individual Drugs Already Approved
Drug Has Already Been Approved
Summary
The investigators are studying the use of Melatonin in non-ventilated patients over the age of 65. Primary endpoint will be assesments of delirium, with secondary endpoints to include length of stay, use of anti-psychotic medications, and mortality
Eligible Conditions
- Delirium
- Melatonin
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Trial Design
3Treatment groups
Active Control
Placebo Group
Group I: Melatonin 5mgActive Control1 Intervention
This arm will be given 5mg tablets of Melatonin nightly for the duration of their hospital stay
Group II: Melatonin 3mgActive Control1 Intervention
This arm will be given 3mg tablets of Melatonin nightly for the duration of their hospital stay
Group III: PlaceboPlacebo Group1 Intervention
This arm will be given a Sucrose tablet nightly for the duration of their hospital stay
Find a Location
Who is running the clinical trial?
MICE Trial GroupLead Sponsor